Patents by Inventor Bodo Brocks

Bodo Brocks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD19 ANTIBODY FORMULATIONS
    Publication number: 20220213190
    Abstract: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
    Type: Application
    Filed: March 22, 2022
    Publication date: July 7, 2022
    Inventors: Patrick GARIDEL, Andreas LANGER, Martin HESSLING, Daniel WEINFURTNER, Bodo BROCKS
  • Anti-CD19 antibody formulations
    Patent number: 11352423
    Abstract: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: June 7, 2022
    Assignee: MORPHOSYS AG
    Inventors: Patrick Garidel, Andreas Langer, Martin Hessling, Daniel Weinfurtner, Bodo Brocks
  • ANTIBODY FORMULATIONS
    Publication number: 20220110872
    Abstract: The present disclosure relates to formulations of a pharmaceutically active antigen binding protein, such as a monoclonal antibody. In particular, the present disclosure relates to a stable lyophilized pharmaceutical formulation of an anti-CD38 antibody, a reconstituted liquid formulation of such lyophilized formulation, and to methods of making and using such lyophilized and reconstituted formulations.
    Type: Application
    Filed: December 13, 2019
    Publication date: April 14, 2022
    Inventors: Bodo BROCKS, Robert KELLERER
  • TREATMENT FOR RHEUMATOID ARTHRITIS
    Publication number: 20210130451
    Abstract: The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.
    Type: Application
    Filed: January 8, 2021
    Publication date: May 6, 2021
    Applicant: MORPHOSYS AG
    Inventors: Stefan HARTLE, Stephane LECLAIR, Amgad SHEBL, Stefan STEIDL, Bodo BROCKS, Daniela Della DUCATA, Kai ROSPORT
  • Treatment for rheumatoid arthritis
    Patent number: 10913792
    Abstract: The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: February 9, 2021
    Assignee: Morphosys AG
    Inventors: Stefan Hartle, Stephane Leclair, Amgad Shebl, Stefan Steidl, Bodo Brocks, Daniela Della Ducata, Kai Rosport
  • ANTI-CD19 ANTIBODY FORMULATIONS
    Publication number: 20190322742
    Abstract: The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 24, 2019
    Inventors: Patrick Garidel, Andreas Langer, Martin Hessling, Daniel Weinfurtner, Bodo Brocks
  • Compositions and methods of use for antibodies of c-Met
    Patent number: 8101727
    Abstract: Antibodies and fragments that bind to the protein target c-Met, particularly to epitopes located in the c-Met extracellular domain, are provided, as are methods of use of the antibodies and kits, for treating an unwanted cell, in particular, a cell associated with a c-Met-related condition such as a cancer, a metastasis, or an inflammatory condition.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: January 24, 2012
    Assignee: Novartis AG
    Inventors: David Raymond Stover, Josef Prassler, Catrin Berger, Bodo Brocks
  • Compositions and Methods of Use for Antibodies of c-Met
    Publication number: 20090175860
    Abstract: Antibodies and fragments that bind to the protein target c-Met, particularly to epitopes located in the c-Met extracellular domain, are provided, as are methods of use of the antibodies and kits, for treating an unwanted cell, in particular, a cell associated with a c-Met-related condition such as a cancer, a metastasis, or an inflammatory condition.
    Type: Application
    Filed: March 29, 2007
    Publication date: July 9, 2009
    Inventors: David Raymond Stover, Josef Prassler, Catrin Berger, Bodo Brocks